About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5897855
Allelic
Composition
Braftm1Mmcm/Braf+
Tg(TPO-cre/ERT2)1139Tyj/0
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1Mmcm mutation (4 available); any Braf mutation (62 available)
Tg(TPO-cre/ERT2)1139Tyj mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• mice administered tamoxifen develop papillary thyroid carcinomas
• tumors show both papillary growth morphology and nuclear features of papillary thyroid carcinoma
• even with very long latency, extrathyroidal invasion is not seen and cervical lymph node metastases are not seen

neoplasm
• mice administered tamoxifen develop papillary thyroid carcinomas
• tumors show both papillary growth morphology and nuclear features of papillary thyroid carcinoma
• even with very long latency, extrathyroidal invasion is not seen and cervical lymph node metastases are not seen

respiratory system
• tamoxifen treated mice generally succumb to respiratory compromise due to tracheal compression by large noninvasive tumors


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/20/2026
MGI 6.24
The Jackson Laboratory